In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr. Arshad Khanani about clinical trials, long term-data and the importance of personalising the treatment to the patient.
In this second episode looking at highlights from the Barcelona congress, we’ll hear about AI and sustainability in ophthalmology from Prof. Jean-francois Korobelnik of University Hospital Bordeaux.
Barcelona, We love you! Over the next few episodes, we’ll be hearing from 3 different sub-specialty experts about their favourite picks from the excellent Euretina Congress this year. This week, we hear from Ms. Rumana Hussain, Consultant Ophthalmologist specialising in Ocular Oncology and VR surgery at Liverpool University Trust Foundation Hospitals.
In this episode, Prof. Nicole Eter speaks with Dr. Yousif Subhi, this year’s Ophthalmologica lecturer about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research.
In this episode, Professor Kyoko Ohno-Matsui discusses advancements in imaging technologies and the management of myopic maculopathy ahead of her keynote lecture at the upcoming Euretina Congress in Barcelona. Chaired by Euretina President, Professor Anat Loewenstein.
Ahead of his prestigious Gisbert Richard lecture at this year’s upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database.
In this episode, Kristina Pfau (Switzerland) and Elon Van Dijk (The Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They’ll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers.
In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar (UK), Principal Optometrist at Moorfields and UCL.
In this podcast, Bart Leroy (Belgium) and Mark Pennesi (USA) discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease).
In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)
In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins University (USA) who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research?
Chaired by Jonathan McCrea (Ireland).
In this episode, we hear from an expert panel as they delve into the critical topic of second eye risk of retinal detachment (RD) and discuss approaches to prophylaxis. With Alistair Laidlaw (UK), Patricia Udaondo (Spain) and David Steel (UK).
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes.
In this podcast episode, we will dig into the subject of radiation maculopathy, the most common complication following the irradiation of intraocular tumours, with a panel of ocular oncologists from across Europe: Hibba Quhill (UK), Iwona Rospond-Kubiak (Poland), Emine Kilic (Netherlands) and Raffaele Parrozzani (Italy).
In this episode we look at two very interesting papers published in the latest editions of Ophthalmologica – Martin Busch (Germany) presents his work on using microRNA as biomarkers for retinal disease and the panel discuss Christina Weisheit’s paper on Co2 emissions from the ophthalmic OR. Chaired by Patricia Udaondo (Spain), Matias Iglicki (Argentina) and Andreas Ebneter (Switzerland).
Secretariat Address
European Society of Retina Specialists
Reinacherstrasse 131
4053 Basel
Switzerland
T +41 61 686 77 91
F +41 61 686 77 88
Email: [email protected]
Newsletter Sign up
Follow us
© EURETINA 2024 All rights reserved